You are here

Demographics

Moderna’s COVID-19 vaccine provides antibodies for at least 6 months after the second dose but fades for older persons

Antibodies persisted 6 months after the second dose of Moderna's COVID-19 vaccine in younger and middle-age adults, but were diminished in older adults when using more sensitive assays, according to data from an ongoing phase I trial.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Demographics
howdy folks